Thursday, August 21, 2014 3:45:22 PM
In March 2014, a commission panel found that Alexander Anderson and Ken Chua
distributed shares of Oriens Travel and Hotel Management Corp. to three B.C. residents
without filing a prospectus, and for which no prospectus exemptions were available.
Oriens raised proceeds of US$58,500.
In its decision, the panel found that, in distributing Oriens shares to investors, Oriens,
Anderson and Chua breached the terms of a CTO against the company. Anderson and
Chua were found to have made misrepresentations to the investors when they failed to
advise them of the CTO.
In its sanctions decision, the panel noted that Chua, “continues to pose a risk to our
investors and our markets” and that Anderson, “had a limited role in the misconduct.”
The panel ordered that Chua resign any position he holds as an officer of a director of an
issuer or registrant. He is banned from trading in securities, purchasing securities or
exchange contracts, and from becoming or acting as a director or officer of any issuer or
registrant for six years. He is also prohibited, for the same period, from becoming or
acting as a registrant or promoter, from engaging in investor relations activities, and from
acting in a management or consultative capacity in connection with the securities market.
Chua was also ordered to pay to the commission the US$58,500 obtained as a result of
his and Oriens’ misconduct. He and Oriens are jointly and severally liable for this
amount. Furthermore, Chua was ordered to pay an administrative penalty of $35,000.
The panel ordered that Anderson resign any position he holds as an officer of a director
of an issuer or registrant (with limited exceptions). He is banned from trading in
securities, purchasing securities or exchange contracts, and from becoming or acting as a
director or officer of any issuer or registrant (with limited exceptions) for two years. He is
also prohibited, for the same period, from becoming or acting as a registrant or promoter,
from engaging in investor relations activities, and from acting in a management or
consultative capacity in connection with the securities market.
British Columbia Securities Commission News Release
Released: August 21, 2014
NR 14-70
BCSC panel sanctions two B.C. residents for illegally distributing securities and breaching a cease trade order
http://www.bcsc.bc.ca/Inc/ViewDoc.asp?DocNum=O7X7L6R5N7N4M7J9K6HDB7G5Y7B3&s=False
distributed shares of Oriens Travel and Hotel Management Corp. to three B.C. residents
without filing a prospectus, and for which no prospectus exemptions were available.
Oriens raised proceeds of US$58,500.
In its decision, the panel found that, in distributing Oriens shares to investors, Oriens,
Anderson and Chua breached the terms of a CTO against the company. Anderson and
Chua were found to have made misrepresentations to the investors when they failed to
advise them of the CTO.
In its sanctions decision, the panel noted that Chua, “continues to pose a risk to our
investors and our markets” and that Anderson, “had a limited role in the misconduct.”
The panel ordered that Chua resign any position he holds as an officer of a director of an
issuer or registrant. He is banned from trading in securities, purchasing securities or
exchange contracts, and from becoming or acting as a director or officer of any issuer or
registrant for six years. He is also prohibited, for the same period, from becoming or
acting as a registrant or promoter, from engaging in investor relations activities, and from
acting in a management or consultative capacity in connection with the securities market.
Chua was also ordered to pay to the commission the US$58,500 obtained as a result of
his and Oriens’ misconduct. He and Oriens are jointly and severally liable for this
amount. Furthermore, Chua was ordered to pay an administrative penalty of $35,000.
The panel ordered that Anderson resign any position he holds as an officer of a director
of an issuer or registrant (with limited exceptions). He is banned from trading in
securities, purchasing securities or exchange contracts, and from becoming or acting as a
director or officer of any issuer or registrant (with limited exceptions) for two years. He is
also prohibited, for the same period, from becoming or acting as a registrant or promoter,
from engaging in investor relations activities, and from acting in a management or
consultative capacity in connection with the securities market.
British Columbia Securities Commission News Release
Released: August 21, 2014
NR 14-70
BCSC panel sanctions two B.C. residents for illegally distributing securities and breaching a cease trade order
http://www.bcsc.bc.ca/Inc/ViewDoc.asp?DocNum=O7X7L6R5N7N4M7J9K6HDB7G5Y7B3&s=False
Recent RMTG News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 03:05:29 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/14/2026 09:20:25 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2026 03:48:57 PM
- RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind • ACCESS Newswire • 03/26/2026 11:55:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 10:12:56 PM
- RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit • ACCESS Newswire • 11/18/2025 12:59:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:59:17 PM
- RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership • ACCESS Newswire • 10/21/2025 11:59:00 AM
- RMTG Expands into Brazil with Strategic Representation Agreement • ACCESS Newswire • 10/14/2025 11:59:00 AM
- RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries • ACCESS Newswire • 10/08/2025 11:59:00 AM
- RMTG Partners with BKFC as Official Regenerative Medicine Provider • ACCESS Newswire • 09/29/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2025 08:32:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/13/2025 08:06:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/30/2025 04:15:10 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/12/2025 01:56:55 AM
